ID: ALA4643669

Max Phase: Preclinical

Molecular Formula: C12H16O6

Molecular Weight: 256.25

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COC(C)CCOC(=O)c1cc(O)c(O)c(O)c1

Standard InChI:  InChI=1S/C12H16O6/c1-7(17-2)3-4-18-12(16)8-5-9(13)11(15)10(14)6-8/h5-7,13-15H,3-4H2,1-2H3

Standard InChI Key:  HOYSUQJWSMXROW-UHFFFAOYSA-N

Associated Targets(Human)

SU.86.86 120 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 256.25Molecular Weight (Monoisotopic): 256.0947AlogP: 1.39#Rotatable Bonds: 5
Polar Surface Area: 96.22Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.11CX Basic pKa: CX LogP: 1.50CX LogD: 1.42
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.54Np Likeness Score: 0.62

References

1. van Stuijvenberg J, Proksch P, Fritz G..  (2020)  Targeting the DNA damage response (DDR) by natural compounds.,  28  (4): [PMID:31980363] [10.1016/j.bmc.2019.115279]

Source